Prevalence of chronic obstructive pulmonary disease and risk factors in Sao Paulo, Brazil, 2008-2009
Carregando...
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
REVISTA DE SAUDE PUBLICA
Autores
SOUSA, Clovis Arlindo de
CESAR, Chester Luiz Galvao
BARROS, Marilisa Berti de Azevedo
CARANDINA, Luana
PEREIRA, Julio Cesar Rodrigues
Citação
REVISTA DE SAUDE PUBLICA, v.45, n.5, p.887-896, 2011
Resumo
OBJECTIVE: To assess the prevalence of chronic obstructive pulmonary disease and related risk factors. METHODS:A population-based cross-sectional study with 1,441 individuals of both sexes aged 40 years or more was conducted in the city of Sao Paulo, Brazil, between 2008 and 2009. A two-stage (census tract, household) cluster random sampling stratified by sex and age was used and data was collected through home interviews. Multiple Poisson regression was used in the adjusted analysis. RESULTS: Of all respondents, 4.2% (95%CI: 3.1;5.4) reported chronic obstructive pulmonary disease. After adjustment the following factors were found independently associated with self-reported chronic obstructive pulmonary disease: number of cigarettes smoked in their lifetime (>1,500 vs. none) (PR=3.85; 95%CI: 1.87;7.94); easily fatigued (yes vs. no) (PR=2.61; 95%CI: 1.39;4.90); age (60;69 vs. 50;59) (PR 3.27; 95%CI: 1.01;11.24); age (70 and over vs. 50;59) (PR 4.29; 95%CI: 1.30;11.29); health conditions in the last 15 days (yes vs. no) (PR=1.31; 95%CI: 1.02;1.77); leisure-time physical activity (yes vs. no) (PR-0.57; 95%CI: 0.26;0.97). CONCLUSIONS: The prevalence of chronic obstructive pulmonary disease is high in the population studied and is associated with smoking and age over 60. Frequent health conditions and low leisure-time physical activity are a consequence of the disease.
Palavras-chave
Pulmonary Disease, Chronic Obstructive, Epidemiology, Risk Factors, Life Style, Cross-Sectional Studies
Referências
- Das UN, 2004, NUTRITION, V20, P323, DOI 10.1016/j.nut.2003.11.017
- Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5
- Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC
- Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649
- Miravitlles M, 2003, CHEST, V123, P784, DOI 10.1378/chest.123.3.784
- Hallberg J, 2008, AM J RESP CRIT CARE, V177, P486, DOI 10.1164/rccm.200704-565OC
- LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324
- FLETCHER C, 1977, BRIT MED J, V1, P1645
- Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605
- Brown DW, 2010, COPD, V7, P59, DOI 10.3109/15412550903499548
- Halbert RJ, 2003, CHEST, V123, P1684, DOI 10.1378/chest.123.5.1684
- Joos L, 2002, SWISS MED WKLY, V132, P27
- [Anonymous], 2004, J BRAS PNEUMOL S5, V30, pS1
- Gosker HR, 2000, AM J CLIN NUTR, V71, P1033
- Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082
- FIEDMAN M, 2001, PHARMACOECONOMICS, V19, P245
- Hirayama F, 2010, J PHYS ACT HEALTH, V7, P622
- Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802
- Menezes Ana Maria Baptista, 2005, Cad Saude Publica, V21, P1565, DOI 10.1590/S0102-311X2005000500030
- MENEZES AMB, 1994, THORAX, V49, P1217, DOI 10.1136/thx.49.12.1217
- Mullerova H, 2004, RESP MED, V98, P78, DOI 10.1016/j/rmed.2003.08.009
- O'Donnell Denis E, 2007, COPD, V4, P225, DOI 10.1080/15412550701480455
- Passowicz-Muszyńska Ewa, 2010, Pneumonol Alergol Pol, V78, P28
- Sousa MH, 2003, REV SAUDE PUBL, V37, P622, DOI [10.1590/S0034-89102003000500018, DOI 10.1590/S0034-89102003000500018]